Experimental Hematology
Volume 37, Issue 1 , Pages 10-18 , January 2009

Podocalyxin selectively marks erythroid-committed progenitors during anemic stress but is dispensable for efficient recovery

  • Steven Maltby

      Affiliations

    • The Biomedical Research Centre, The University of British Columbia, Vancouver, Canada
    • Drs. Maltby and Hughes contributed equally to this work.
    • ,
  • Michael R. Hughes

      Affiliations

    • The Biomedical Research Centre, The University of British Columbia, Vancouver, Canada
    • Drs. Maltby and Hughes contributed equally to this work.
    • ,
  • Lori Zbytnuik

      Affiliations

    • The Biomedical Research Centre, The University of British Columbia, Vancouver, Canada
    • ,
  • Robert F. Paulson

      Affiliations

    • Center for Molecular Immunology and Infectious Disease, Department of Veterinary and Biomedical Sciences, The Pennsylvania State University, University Park, Pa., USA
    • ,
  • Kelly M. McNagny

      Affiliations

    • The Biomedical Research Centre, The University of British Columbia, Vancouver, Canada
    • Corresponding Author InformationOffprint requests to: Kelly M. McNagny, Ph.D., The Biomedical Research Centre, University of British Columbia, 2222 Health Sciences Mall, Vancouver, British Columbia, V6T 1Z3 Canada

Received 4 June 2008 ,Revised 10 September 2008 ,Accepted 11 September 2008.

References 

  1. Socolovsky M. Molecular insights into stress erythropoiesis. Curr Opin Hematol. 2007;14:215–224
  2. Ebert BL, Bunn HF. Regulation of the erythropoietin gene. Blood. 1999;94:1864–1877
  3. Broudy VC, Lin NL, Priestley GV, Nocka K, Wolf NS. Interaction of stem cell factor and its receptor c-kit mediates lodgment and acute expansion of hematopoietic cells in the murine spleen. Blood. 1996;88:75–81
  4. Perry JM, Harandi OF, Paulson RF. BMP4, SCF, and hypoxia cooperatively regulate the expansion of murine stress erythroid progenitors. Blood. 2007;109:4494–4502
  5. Lenox LE, Perry JM, Paulson RF. BMP4 and Madh5 regulate the erythroid response to acute anemia. Blood. 2005;105:2741–2748
  6. Bauer A, Tronche F, Wessely O, et al. The glucocorticoid receptor is required for stress erythropoiesis. Genes Dev. 1999;13:2996–3002
  7. Kerjaschki D, Sharkey DJ, Farquhar MG. Identification and characterization of podocalyxin—the major sialoprotein of the renal glomerular epithelial cell. J Cell Biol. 1984;98:1591–1596
  8. Dekan G, Gabel C, Farquhar MG. Sulfate contributes to the negative charge of podocalyxin, the major sialoglycoprotein of the glomerular filtration slits. Proc Natl Acad Sci U S A. 1991;15(88):5398–5402
  9. Furness SG, McNagny K. Beyond mere markers: functions for CD34 family of sialomucins in hematopoiesis. Immunol Res. 2006;34:13–32
  10. Kershaw DB, Thomas PE, Wharram BL, et al. Molecular cloning, expression, and characterization of podocalyxin-like protein 1 from rabbit as a transmembrane protein of glomerular podocytes and vascular endothelium. J Biol Chem. 1995;270:29439–29446
  11. Horvat R, Hovorka A, Dekan G, Poczewski H, Kerjaschki D. Endothelial cell membranes contain podocalyxin—the major sialoprotein of visceral glomerular epithelial cells. J Cell Biol. 1986;102:484–491
  12. Hara T, Nakano Y, Tanaka M, et al. Identification of podocalyxin-like protein 1 as a novel cell surface marker for hemangioblasts in the murine aorta-gonad-mesonephros region. Immunity. 1999;11:567–578
  13. Doyonnas R, Kershaw DB, Duhme C, et al. Anuria, omphalocele, and perinatal lethality in mice lacking the CD34–related protein podocalyxin. J Exp Med. 2001;194:13–27
  14. McNagny KM, Pettersson I, Rossi F, et al. Thrombomucin, a novel cell surface protein that defines thrombocytes and multipotent hematopoietic progenitors. J Cell Biol. 1997;138:1395–1407
  15. Doyonnas R, Nielsen JS, Chelliah S, et al. Podocalyxin is a CD34–related marker of murine hematopoietic stem cells and embryonic erythroid cells. Blood. 2005;105:4170–4178
  16. Kerosuo L, Juvonen E, Alitalo R, Gylling M, Kerjaschki D, Miettinen A. Podocalyxin in human haematopoietic cells. Br J Haematol. 2004;124:809–818
  17. Somasiri A, Nielsen JS, Makretsov N, et al. Overexpression of the anti-adhesin podocalyxin is an independent predictor of breast cancer progression. Cancer Res. 2004;64:5068–5073
  18. Casey G, Neville PJ, Liu X, et al. Podocalyxin variants and risk of prostate cancer and tumor aggressiveness. Hum Mol Genet. 2006;15:735–741
  19. Sizemore S, Cicek M, Sizemore N, Ng KP, Casey G. Podocalyxin increases the aggressive phenotype of breast and prostate cancer cells in vitro through its interaction with ezrin. Cancer Res. 2007;67:6183–6191
  20. Drew E, Merzaban JS, Seo W, Ziltener HJ, McNagny KM. CD34 and CD43 inhibit mast cell adhesion and are required for optimal mast cell reconstitution. Immunity. 2005;22:43–57
  21. Blanchet MR, Maltby S, Haddon DJ, Merkens H, Zbytnuik L, McNagny KM. CD34 facilitates the development of allergic asthma. Blood. 2007;110:2005–2012
  22. Gounaris E, Erdman SE, Restaino C, et al. Mast cells are an essential hematopoietic component for polyp development. Proc Natl Acad Sci U S A. 2007;104:19977–19982
  23. Porayette P, Paulson RF. BMP4/Smad5 dependent stress erythropoiesis is required for the expansion of erythroid progenitors during fetal development. Dev Biol. 2008;317:24–35
  24. Sathyanarayana P, Menon MP, Bogacheva O, et al. Erythropoietin modulation of podocalyxin, and a proposed erythroblast niche. Blood. 2007;110:509–518
  25. Zang H, Sato K, Nakajima H, McKay C, Ney PA, Ihle JN. The distal region and receptor tyrosines of the epo receptor are non-essential for in vivo erythropoiesis. EMBO J. 2001;20:3156–3166
  26. Riley RS, Ben-Ezra JM, Goel R, Tidwell A. Reticulocytes and reticulocyte enumeration. J Clin Lab Anal. 2001;15:267–294
  27. Riley RS, Ben-Ezra JM, Tidwell A, Romagnoli G. Reticulocyte analysis by flow cytometry and other techniques. Hematol Oncol Clin North Am. 2002;16:373–420vii
  28. Liu Y, Pop R, Sadegh C, Brugnara C, Haase VH, Socolovsky M. Suppression of fas-FasL coexpression by erythropoietin mediates erythroblast expansion during the erythropoietic stress response in vivo. Blood. 2006;108:123–133
  29. Jackson CW. Cholinesterase as a possible marker for early cells of the megakaryocytic series. Blood. 1973;42:413–421
  30. Socolovsky M, Nam H, Fleming MD, Haase VH, Brugnara C, Lodish HF. Ineffective erythropoiesis in Stat5a(–/–)5b(–/–) mice due to decreased survival of early erythroblasts. Blood. 2001;98:3261–3273
  31. Miettinen A, Solin ML, Reivinen J, Juvonen E, Vaisanen R, Holthofer H. Podocalyxin in rat platelets and megakaryocytes. Am J Pathol. 1999;154:813–822
  32. Baumheter S, Singer MS, Henzel W, et al. Binding of L–selectin to the vascular sialomucin CD34. Science. 1993;262:436–438
  33. Fieger CB, Sassetti CM, Endoglycan Rosen SD. a member of the CD34 family, functions as an L–selectin ligand through modification with tyrosine sulfation and sialyl Lewis x. J Biol Chem. 2003;278:27390–27398
  34. Sarangapani KK, Yago T, Klopocki AG, et al. Low force decelerates L–selectin dissociation from P–selectin glycoprotein ligand–1 and endoglycan. J Biol Chem. 2004;279:2291–2298
  35. Sassetti C, Tangemann K, Singer MS, Kershaw DB, Rosen SD. Identification of podocalyxin–like protein as a high endothelial venule ligand for L–selectin: parallels to CD34. J Exp Med. 1998;187:1965–1975

PII: S0301-472X(08)00435-9

doi: 10.1016/j.exphem.2008.09.006

Experimental Hematology
Volume 37, Issue 1 , Pages 10-18 , January 2009

Article Tools

* Image Usage & Resolution